ESMO Highlights: Breast cancer

Research shows chemotherapy has no negative effects on babies in utero

Importance of gynaecological surgeons and multidisciplinary strategies in advanced ovarian cancer

Raising awareness about head and neck cancer through the Make Sense campaign

Cancer care in developing countries

Dabrafenib plus trametinib preferable to vemurafenib alone in melanoma

Nivolumab potentially superior to standard chemo in advanced melanoma

Targeted therapy for iodine-refractory thyroid cancer

Questions raised about the future of lung cancer vaccination?

PD-L1 protein a possible immunotherapy target in mesothelioma

Improved response rate and survival with dabrafenib plus trametinib versus vemurafenib alone in melanoma

Vemurafenib plus cobimetinib achieves significant progression-free survival in melanoma